GSK Investigational Site

Cottbus 03050

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma — Completed
• Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed